Skip to content

    Altimmune (ALT) stock price & financials

    View ALT earnings calls

    Overview

    Price

    Market Cap

    Sector

    Rank

    Performance15.3% 1Y

    Financials

    Income Statement

    Financial Trajectories

    11
    Quarterly
    MetricQ3 FY24Q4 FY24Q1 FY25Q2 FY25Q3 FY25Q4 FY25Q1 FY26Q2 FY26Trend
    EarningsRevenue
    $5.0K
    $5.0K
    $5.0K
    $5.0K
    $5.0K
    +0.0%
    $26.0K
    +420.0%
    Strengthening
    Operating Profit
    -$24.77M
    -$24.87M
    -$21.82M
    -$22.92M
    -$20.86M
    +15.8%
    -$28.89M
    -16.2%
    -$24.24M
    -11.1%
    -$26.23M
    -14.4%
    Weakening
    Net Profit
    -$22.84M
    -$23.18M
    -$19.57M
    -$22.15M
    -$19.01M
    +16.8%
    -$27.36M
    -18.0%
    -$22.56M
    -15.3%
    -$22.82M
    -3.1%
    Weakening
    EPS
    $-0.32
    $-0.26
    $-0.27
    $-0.21
    +34.4%
    $-0.18
    +30.8%
    $-0.12
    +55.6%
    Strengthening
    Other Income
    $1.92M
    $1.69M
    $1.56M
    $776.0K
    $1.84M
    -4.0%
    $1.53M
    -9.0%
    $1.68M
    +7.8%
    $3.40M
    +338.7%
    Strengthening
    Interest
    $6.0K
    $1.0K
    $1.0K
    $264.0K
    $495.0K
    +8150.0%
    $876.0K
    +87500.0%
    $1.07M
    +106700.0%
    $1.10M
    +315.5%
    Strengthening
    Depreciation
    Profit before Tax
    -$22.84M
    -$23.18M
    -$20.26M
    -$22.15M
    -$19.01M
    +16.8%
    -$27.36M
    -18.0%
    -$22.56M
    -11.4%
    -$22.82M
    -3.1%
    Weakening
    MarginsOPM
    -495340.0%
    -497320.0%
    -436300.0%
    -458440.0%
    -417180.0%
    +15.8%
    -111126.9%
    +77.7%
    Strengthening
    Tax
    0.0%
    3.4%
    ReturnsROIC
    3.3%
    3.3%
    2.8%
    3.2%
    2.7%
    -16.8%
    3.9%
    +18.0%
    3.2%
    +15.3%
    3.3%
    +3.1%
    Strengthening

    Balance Sheet

    Balance Sheet

    USD · Annual
    Line itemFY18FY19FY20FY21FY22FY23FY24FY25TTM
    AssetsCash & Equivalents$33.72M$8.96M$115.92M$190.30M$111.10M$135.12M$36.93M$43.76M$63.01M
    Short-Term Investments
    Total Current Assets$39.37M$39.39M$230.26M$204.13M$192.81M$209.63M$137.25M$278.19M$334.81M
    Net PP&E$1.34M$1.80M$1.96M$2.25M$1.68M$1.01M$2.05M$1.74M$60.0K
    Goodwill$0$0
    Intangibles$13.85M$12.73M$12.82M$12.42M$12.42M$0$0
    Total Assets$54.75M$54.06M$245.12M$218.87M$206.93M$210.64M$139.31M$279.93M$527.21M
    LiabilitiesTotal Current Liabilities$4.53M$3.92M$12.02M$18.28M$17.05M$12.14M$10.47M$15.00M$12.50M
    Short-Term Debt
    Long-Term Debt$1.85M$1.86M$1.83M$1.45M$4.58M$34.29M$34.74M
    Long-Term Leases$1.48M$1.47M$1.12M$672.0K$175.0K$1.40M$1.15M$1.00M
    Total Liabilities$6.44M$8.54M$19.24M$19.73M$21.64M$16.54M$15.80M$55.04M$53.00M
    EquityCommon Stock & APIC$876$1.5K$3.7K$4.0K$5.0K$7.0K$7.0K$11.0K$19.0K
    Retained Earnings-$116.86M-$137.38M-$186.42M-$293.17M-$377.88M-$466.33M-$561.39M-$649.48M-$694.87M
    Total Equity$48.31M$45.52M$225.88M$199.13M$185.29M$194.10M$123.51M$224.89M$474.21M
    HighlightsNet Cash / (Debt)

    Cash Flow

    Cash Flow

    USD · Annual
    Line itemFY18FY19FY20FY21FY22FY23FY24FY25TTM
    ActivitiesCash from Operating-$9.39M-$9.60M-$34.31M-$78.24M-$62.59M-$75.81M-$79.85M-$67.53M-$76.51M
    Cash from Investing-$1.00M-$28.29M-$72.23M$87.52M-$73.40M$13.73M-$28.39M-$132.47M-$453.61M
    Cash from Financing$32.49M$12.53M$213.49M$65.10M$56.78M$86.11M$10.04M$206.84M$410.02M
    SummaryCapital Expenditure-$975.4K-$1.2K-$204.0K-$12.12M-$126.0K-$47.0K-$11.0K-$54.0K
    Free Cash Flow-$10.36M-$9.60M-$34.51M-$90.36M-$62.71M-$75.86M-$67.55M-$76.56M
    FCF Margin-100.3%-165.5%-421.6%-2048.9%92223.5%-17806.8%-164746.3%

    Ratios